Results 51 to 60 of about 1,201 (192)

Ergotism in the past. The role of ergot during the witch-hunts and its use in the medicine in 19th century

, 2021
Cieľom tohto príspevku štúdie je ukázať, akú úlohu zohral námeľ ako pôvodca ergotizmu v minulosti. Štúdia prináša charakteristiku ergotizmu a dáva ergotizmus do historických súvislostí.
Ondreička, Peter
core  

What's Needed for a Migraine Cost‐Of‐Illness Study in Aotearoa New Zealand: Review of Data Sources and Gaps

Journal of the Royal Society of New Zealand, Volume 56, Issue 3, June 2026.
Cost of illness (COI) studies are used to quantify the economic burden of disease on health systems, employers and society, and identify where costs may be saved by improvements in disease management. Many migraine COI studies have been published internationally but none have included data from Aotearoa New Zealand (NZ), despite the known high ...
Fiona Imlach, Sofiia Tsaregorodtseva, Maite Irurzun‐Lopez, William Leung, Calvin Chan, Ray Bose   +5 more
wiley   +1 more source

Use of ergotamine: Do physicians in Colombia know how to prescribe it?

Neurología (English Edition), 2014
Introduction: Ergot derivatives are drugs with vasoconstrictor effects that are used to abort migraine attacks. This study aims to determine how ergotamine derivatives are prescribed by physicians in Colombia, find variables associated with inappropriate
J.E. Machado-Alba, C.D. Morales-Plaza
doaj   +1 more source

A role for platelet-derived growth factor in drug-induced chronic ergotism?:A case report

, 1995
Generalized vasoconstriction in chronic ergot poisoning is attributed both to the ergotamine activity on alpha-adrenergic receptors and to its direct action on vascular smooth muscle cells.
Caenazzo, A., Polato, G., Dazzi, F.; id_orcid, Girolami, A., Pietrogrande, F.   +4 more
core   +1 more source

Utilización de ergotamina: ¿saben los médicos en Colombia cómo prescribirla?

Neurología, 2014
Resumen: Introducción: Los derivados ergotamínicos son medicamentos para abortar las crisis migrañosas, con un efecto vasoconstrictor, que poseen una forma específica de formulación.
J.E. Machado-Alba, C.D. Morales-Plaza
doaj   +1 more source

Is the endophyte‐based plant protection against aphids mediated by changes in the insect microbiome?

Insect Science, Volume 33, Issue 3, Page 1097-1108, June 2026.
We showed that the fungal endophyte Epichloë strain AR37 increased the plant resistance against aphids via the production of indole diterpene alkaloids. The reduction in aphid performance was not associated with changes in abundance/composition/diversity of the insect's bacterial microbiota, but additional endophyte effects on this microbiota cannot be
Daniel A. Bastías, Luis Carvalho, Ruy Jáuregui, Richard D. Johnson, Wei Zhang, Pedro E. Gundel   +5 more
wiley   +1 more source

Kidney supportive care in Australia and New Zealand: an Australian and New Zealand Society of Nephrology (ANZSN) and Australian and New Zealand Society of Palliative Medicine (ANZSPM) guidance document

Internal Medicine Journal, Volume 56, Issue S2, Page 4-48, June 2026.
The purpose of this document is to provide a summary of the current expert opinion and recent literature for clinicians, Indigenous health workers and patient advocates interested in Kidney Supportive Care (KSC) in Australia and New Zealand. Our purpose is not to duplicate the recently released International Society of Nephrology (ISN) KSC/Conservative
Kathryn Ducharlet, Frank Brennan, Rajesh Raj, Charlotte Ogivly, Elizabeth Stallworthy, Kelly Chenlei Li, Alice Kennard, Selina Bob, Nicole Scholes‐Robertson, Riona Pais, Jenny Chen, Kirsten Hepburn, Lisa Jeffs, Ilse Berquier, Jacquelyne Hughes, Christine Sanderson, Sara Rendo, Gowri Raman, Erin Vaughan, Sarah So, Curtis Walker, Suetonia Green, Rangimarie Nadia Glavish, Mark Brown   +23 more
wiley   +1 more source

Dopamine D2 Receptor Agonists as Modulators of VEGF‐A‐Driven Angiogenesis: Mechanisms, Clinical Evidence, and Translational Opportunities

The FASEB Journal, Volume 40, Issue 9, 15 May 2026.
Interplay between VEGF‐A‐driven angiogenesis and DRD2‐mediated inhibition. Tumor‐derived VEGF‐A activates VEGFR2 on endothelial cells, triggering proangiogenic signaling pathways that promote abnormal vessel growth and vascular leakage. VEGF‐A also induces DRD2 expression, establishing a feedback mechanism.
Venu Akkanapally, Aman Kumar, Inemai Ezhil, Manas Ranjan Sahu, Xue‐Feng Bai, Kamal S. Pohar, Sujit Basu   +6 more
wiley   +1 more source

Synthesis of Amines for Active Pharmaceutical Ingredients Using the Whole‐Cell Factory Saccharomyces Cerevisae

ChemBioChem, Volume 27, Issue 9, 14 May 2026.
This review highlights advances in engineering Saccharomyces cerevisiae for the sustainable biocatalytic production of pharmaceutically relevant amines, amino alcohols, amino acids, and complex alkaloids. It focuses on strategies to increase productivity, including enhanced enzyme expression, cofactor regeneration, precursor channeling, pathway ...
Natalia Kwiatos, Stephen Ossel, Francesco G. Mutti   +2 more
wiley   +1 more source

Twenty-eight Year Old HIV Positive Male Patient with Ergotism. Interaction of Ergot-alkaloids and Protease-inhibitors

, 2005
Ergotism is a rare clinical condition caused by ergot-alkaloid intoxication or pharmacodynamic interactions. The pathophysiology is based on arterial spasm in different segments of the arterial tree. Ergot-alkaloids are frequently prescribed as treatment
Mlekusch, W., Schillinger, M., Minar, E.
core   +1 more source